The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Innovation Medical Management Co., Ltd. (hereinafter referred to as "the Company") held the third interim meeting of the seventh board of directors on June 1, 2026, where it reviewed and approved the proposal on the buyback of certain public shares. The specific details can be found in the announcement disclosed by the Company on June 2, 2026, on the Giant Tide Information Network (www.cninfo.com.cn).
In accordance with the "Self-Regulatory Guidelines No. 9 for Listed Companies on the Shenzhen Stock Exchange - Share Buybacks" and other relevant regulations, the Company hereby announces the names and shareholding quantities and proportions of the top ten shareholders and top ten unrestricted shareholders registered on the trading day prior to the board's announcement of the share buyback resolution (i.e., June 1, 2026):